| 201 |
|
Creatinine Measurement Proficiency Testing: Assignment of Matrix-Adjusted ID GC-MS Target Values
|
Carobene, A
|
American Association for Clinical Chemistry
|
1980
|
|
|
|
| 202 |
|
Critical Difference Between Serial Measurements of CK-MB Mass to Detect Myocardial Damage
|
De Winter, R. J
|
American Association for Clinical Chemistry
|
1980
|
|
|
|
| 203 |
|
Cross-Linking Hybridization Assay for Direct Detection of Factor V Leiden Mutation
|
Zehnder, J
|
American Association for Clinical Chemistry
|
1980
|
|
|
|
| 204 |
|
CryoSeal[TM] System, a New Device for Generating Cryoprecipitate from Plasma
|
Gosselin, R. C
|
American Association for Clinical Chemistry
|
1980
|
|
|
|
| 205 |
|
Current Status and Performance Goals for Serum Thyroglobulin Assays
|
Spencer, C. A
|
American Association for Clinical Chemistry
|
1980
|
|
|
|
| 206 |
|
Current Status and Performance Goals for Serum Thyrotropin (TSH) Assays
|
Spencer, C. A
|
American Association for Clinical Chemistry
|
1980
|
|
|
|
| 207 |
|
Cytochrome P-450 Isoforms Implicated in Ochratoxin A Genotoxicity Determined by DNA Adduct Formation
|
Grosse, Y
|
American Association for Clinical Chemistry
|
1980
|
|
|
|
| 208 |
|
Daidzein and Genistein Concentrations in Human Milk After Soy Consumption
|
Franke, A. A
|
American Association for Clinical Chemistry
|
1980
|
|
|
|
| 209 |
|
Data Processing in CO-Oximeters That Use Overdetermined Systems
|
Yukawa, N
|
American Association for Clinical Chemistry
|
1980
|
|
|
|
| 210 |
|
Data Processing in CO-Oximeters That Use Overdetermined Systems: Reply
|
Brunelle, J. A
|
American Association for Clinical Chemistry
|
1980
|
|
|
|
| 211 |
|
Decision-Making Laboratory Computer Systems as Essential Tools for Achievement of Total Quality
|
Blick, K
|
American Association for Clinical Chemistry
|
1980
|
|
|
|
| 212 |
|
Decline in Blood Lead in Ontario Children Correlated to Decreasing Consumption of Leaded Gasoline, 1983-1992
|
Wang, S. T
|
American Association for Clinical Chemistry
|
1980
|
|
|
|
| 213 |
|
Defining the Best Quality-Control Systems by Design and Inspection
|
Hinckley, C. M
|
American Association for Clinical Chemistry
|
1980
|
|
|
|
| 214 |
|
Defining the Smallest Analyte Concentration an Immunoassay Can Measure
|
Brown, F. N
|
American Association for Clinical Chemistry
|
1980
|
|
|
|
| 215 |
|
DELISA: Sensitive Nonisotopic Assay for GAD~6~.~5 Autoantibodies, a Key Risk-Assessment Marker for Insulin-Dependent Diabetes Mellitus
|
Mehta, H. B
|
American Association for Clinical Chemistry
|
1980
|
|
|
|
| 216 |
|
Delivering Clinical Laboratory Services to Intensive Care Units
|
Steffes, M. W
|
American Association for Clinical Chemistry
|
1980
|
|
|
|
| 217 |
|
Denaturing Gradient-Gel Electrophoresis Screening of Familial Defective Apolipoprotein B-100 in a Mixed Asian Cohort: Two Cases of Arginine~3~5~0~0 ->Tryptophan Mutation Associated with a Unique Haplotype
|
Choong, M.-L
|
American Association for Clinical Chemistry
|
1980
|
|
|
|
| 218 |
|
Designing in Quality Through Design Control: A Manufacturer's Perspective
|
Lasky, F. D
|
American Association for Clinical Chemistry
|
1980
|
|
|
|
| 219 |
|
Detecting CFTR Gene Mutations by Using Primer Oligo Base Extension and Mass Spectrometry
|
Braun, A
|
American Association for Clinical Chemistry
|
1980
|
|
|
|
| 220 |
|
Detecting Familial Defective Apolipoprotein B-100: Three Molecular Scanning Methods Compared
|
Henderson, B. G
|
American Association for Clinical Chemistry
|
1980
|
|
|
|